Journals / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 3

Effects of Topical Timolol Maleate on Anterior Segment Structure, Pupil Dynamics and Retinal and Choroidal Thickness in Healthy Subjects

Pages
174–180
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Topical BAC-preserved timolol maleate reduces pupil dilation speed without any effect on static pupil functions and increases the CCT and central macular thickness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the effect of a single dose of topical timolol maleate 0.5% on anterior segment structure, pupil dynamics, and retinal and choroidal thickness in healthy subjects.
📊
Key Findings & Data:Materials and Methods: Thirty subjects were included in this prospective and observational study.One eye of the participants received a single dose of topical benzalkonium chloride (BAC) preserved Timolol maleate 0.5% (Timosol 0.5%, Bilim Ilac, Istanbul, Turkey) (treated eye).
💡
Conclusion & Impact:Conclusion: Topical BAC-preserved timolol maleate reduces pupil dilation speed without any effect on static pupil functions and increases the CCT and central macular thickness.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: To investigate the effect of a single dose of topical timolol maleate 0.5% on anterior segment structure, pupil dynamics, and retinal and choroidal thickness in healthy subjects. Materials and Methods: Thirty subjects were included in this prospective and observational study.One eye of the participants received a single dose of topical benzalkonium chloride (BAC) preserved Timolol maleate 0.5% (Timosol 0.5%, Bilim Ilac, Istanbul, Turkey) (treated eye). Contralateral eye received a single dose of sodium hyaluronate ophthalmic solution without preservative (control eye). Main outcome measures were central corneal thickness (CCT), aqueous depth, anterior chamber volume, iridocorneal angle, horizontal anterior chamber diameter, static and dynamic pupil functions, central macular thickness, and choroidal thickness. Results: Mean CCT was signifi cantly higher after timolol instillation in treated eyes (p=0.001). Timolol did not affect aqueous depth, anterior chamber volume, iridocorneal angle and horizontal anterior chamber diameter in treated eyes (p>0.05 for each). Mean pupil diameters were similar under scotopic, mesopic and photopic conditions before and after timolol instillation (p>0.05 for each); however, pupil dilation speed was signifi cantly lower after timolol instillation in the treated eyes (p 0.05). Pre- and post-instillation outcomes were similar in control eyes for all parameters (p>0.05 for each). Conclusion: Topical BAC-preserved timolol maleate reduces pupil dilation speed without any effect on static pupil functions and increases the CCT and central macular thickness.

🔖

Cite This Article

CANKURTARAN, V., OZATES, S. (2020). Effects of Topical Timolol Maleate on Anterior Segment Structure, Pupil Dynamics and Retinal and Choroidal Thickness in Healthy Subjects. Glokom Katarakt, Cilt: 15 - Sayı: 3, 174–180. https://ajindex.com/articles/157140

References (16)

  1. Uusitalo H, Kahonen M, Ropo A, et al. The evaluation of effi cacy and systemic side effects of topical antiglaucoma drugs: the benefi ts of improved drug formulation. J Glaucoma. 1999;8:264-5
  2. Coakes RL, Brubaker RF. The mechanism of timolol in lowering intraocular pressure. In the normal eye. Arch Ophthalmol. 1978;96:2045-8
  3. Crook RB, Riese K. Beta-adrenergic stimulation of Na+, K+, Cl- cotransport in fetal nonpigmented ciliary epithelial cells. Invest Ophthalmol Vis Sci. 1996;37:1047-57
  4. McLaughlin CW, Peart D, Purves RD, et al. Timolol may inhibit aqueous humor secretion by cAMP-independent action on ciliary epithelial cells. Am J Physiol Cell Physiol. 2001;281:865-75
  5. Wax MB, Molinoff PB. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987;28:420-30
  6. Frambach DA, Fain GL, Farber DB, et al. Beta adrenergic receptors on cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990;31:1767-72
  7. Wax MB, Molinoff PB, Alvarado J, et al. Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989;30:51-7
  8. Elena PP, Denis P, Kosina-Boix M, et al. Beta adrenergic binding sites in the human eye: an autoradiographic study. J Ocul Pharmacol. 1990;6:143-9
  9. Zimmerman TJ, Kaufman HE. Timolol, dose response and duration of action. Arch Ophthalmol. 1977;95:605-7
  10. Boger III WP. Shortterm “escape” and longterm “drift.”. The dissipation effects of the beta adrenergic blocking agents. Surv Ophthalmol. 1983;28:235-40
  11. Oksala A, Salminen L. Tachyphylaxis in timolol therapy for chronic glaucoma. Klin Monbl Augenheilkd. 1980;177:451- 4
  12. Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17:190-5
  13. Zele AJ, Feigl B, Smith SS, et al. The circadian response of intrinsically photosensitive retinal ganglion cells. PLoS One. 2011;6:e17860
  14. Prakash G, Srivastava D, Suhail M, et al. Assessment of bilateral pupillary centroid characteristics at varying illuminations and post-photopic fl ash response using an automated pupillometer. Clin Exp Optom. 2016;99:535-43
  15. Schwartz GF, Quigley HA. Adherence and Persistence with Glaucoma Therapy. Surv Ophthalmol. 2008;53:57-68
  16. Winn B, Culhane HM, Gilmartin B, et al. Effect of betaadrenoceptor antagonists on autonomic control of ciliary smooth muscle. Ophthalmic Physio